[1] |
Moayyeri A, Soltani A, Bahrami H, et al. Preferred skeletal site for osteoporosis screening in high-risk populations[J]. Public health, 2006, 120(9):863-871.
|
[2] |
Ding GZ, Liu ZH, Zhou Y. Clinical progress of integrative medicine in treating osteoporosis[J]. Chin J Osteoporos, 1997, 3(2):81-84.
|
[3] |
Report of a WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis[R]. WHO Technical Report Series, 1994, 843.
|
[4] |
Kanis JA, Melton LJ Ⅲ, Christiansea C, et al. The diagnosis of osteoporosis[J]. J Bone Miner Res, 1994, 9:1137-1141.
|
[5] |
Report of a WHO Scientific Group. Prevention and management of osteoporosis[R]. WHO Tech Report Series, 2003, 921.
|
[6] |
Wang HF. Diagnosis of osteoporosis[J]. Intern J Endocrinol Metab, 2006, 26:285-288.
|
[7] |
Wu TX, Liu GJ. The concepts, design, practice and reports of allocation concealment and blinding[J]. Chin J Evid-based Med, 2007, 7(3):222-225.
|
[8] |
Heikkinen J, Kyllnen E, Kurttila-Matero E, et al. HRT and exercise: Effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women[J]. Maturitas, 1997, 26(2):139-149.
|
[9] |
Komulainen M, Krger H, Tuppurainen MT, et al. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: A population-based 5-year randomized trial[J]. J Clin Endocrinol Metab, 1999, 84(2):546-552.
|
[10] |
Heikkinen J, Vaheri R, Kainulainen P, et al. Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: A comparison of high- and low-dose estrogen-progestin regimens[J]. Osteoporos Int, 2000, 11(11):929-937.
|
[11] |
Lu JL, Lin SQ, Zhang LS, et al. Prevention of bone loss by estradiol valerate combined with medroxyprogesterone acetate among postmenopausal women with osteopenia[J]. Natl Med J China, 2002, 82(23):1593-1598.
|
[12] |
Komulainen M, Tuppurainen MT, Krger H, et al. Vitamin D and HRT: No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study[J]. Osteoporos Int, 1997, 7(2):126-132.
|